The funding granted by the Innovative Health Initiative (IHI) is based on a model of blended finance, where EU funding is matched by contributions from IHI's industry partners and (in some projects) other organisations such as philanthropic foundations.

The majority (around 90%) of the industry contribution to IHI projects is ‘in-kind’. In-kind contributions include scientific and regulatory expertise; unique data, assets and compounds; and access to state-of-the-art research infrastructure and cutting-edge technology. Crucially, these private sector in-kind contributions complement the skills, expertise and resources brought into the project by the ‘public’ partners such as universities and patient organisations.

During this webinar, representatives of IHI projects will:

• explain how in-kind contributions allowed the projects to deliver results that would not have been possible otherwise; 
• demonstrate how in-kind contributions incentivise the uptake and exploitation of project results; 
• describe how in-kind contributions drive additional activities within and across companies by combining outcomes from several projects. 

More information about the event and registration on the IHI website.